clinical guidelines

1 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Not Specified

Amarin Posts 7% Revenue Growth in Q1 2026 Amid Strong VASCEPA Momentum

Amarin reports Q1 2026 revenue of $45.1M (up 7%), narrows operating losses 33%, maintains debt-free balance with $307.8M cash.
RICFYrevenue growthinternational expansion